TRADING UPDATES: MedPal acquisition; Helix begins helium sales
20th Jul 2026 21:55
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 30.00p on 02-10-2026 at 18:15:10 |
|---|---|
| Change | -1.00p -3.23% |
| Buy | 31.00p |
| Sell | 29.00p |
| Last Trade: | Buy 25,000.00 at 30.60p |
| Day's Volume: | 746,165 |
| Last Close: | 30.00p |
| Open: | 31.00p |
| ISIN: | GB00BMC3RJ87 |
| Day's Range | 29.50p - 31.00p |
| 52wk Range: | 9.00p - 39.00p |
| Market Capitalisation: | £41.92m |
| VWAP: | 29.94009p |
| Shares in Issue: | 139.73m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Sareum (SAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 25,000 | 30.60p | Ordinary |
16:28:16 - 02-Oct-26 |
| Buy* | 15,000 | 30.749p | Ordinary |
16:10:05 - 02-Oct-26 |
| Sell* | 3,120 | 29.632p | Ordinary |
16:09:23 - 02-Oct-26 |
| Buy* | 25,000 | 30.80p | Suspected BUY Trade |
15:58:53 - 02-Oct-26 |
| Buy* | 6,198 | 30.42p | Ordinary |
15:50:23 - 02-Oct-26 |
| Buy* | 32,750 | 30.45p | Ordinary |
15:39:34 - 02-Oct-26 |
| Buy* | 3,284 | 30.45p | Ordinary |
15:39:31 - 02-Oct-26 |
| Buy* | 322 | 31.00p | Ordinary |
15:34:11 - 02-Oct-26 |
| Sell* | 10,450 | 29.50p | Ordinary |
15:16:48 - 02-Oct-26 |
| Buy* | 3,284 | 30.45p | Ordinary |
15:12:43 - 02-Oct-26 |
Sareum (SAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Sep 2026 5:29 pm | RNS | Exercise of Warrants |
| 19th Aug 2026 2:19 pm | RNS | Exercise of Warrants |
| 7th Aug 2026 1:28 pm | RNS | Exercise of Warrants |
| 20th Jul 2026 7:00 am | RNS | Completion of Dosing in Toxicology Programme |
| 22nd Jun 2026 9:40 am | RNS | Publication of Phase 1 data on SDC-1801 in BJCP |
| 1st May 2026 7:00 am | RNS | Exercise of Warrants |
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 3rd Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 17th Feb 2026 7:00 am | RNS | Restart of Phase 2-enabling toxicology programme |